IL7 and diabetes mellitus: IL-7/M25 treatment of recipient mice starting as early as day 2 after cell transfer shortened the lapse of time until diabetes development to day 11.5 ± 1.0 if only diabetogenic CD4+BDC2.5+ T cells were transferred (Figure 5B, right; P < 0.05).